✨ Free AI Report
Faes Farma, S.A.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Faes Farma, S.A.
Company Research

Faes Farma, S.A.: Business Overview, Financials & Competitive Analysis

Faes Farma, S.A. scores 6/10 on the AskCyborg Cyborg Score (Solid). Established Spanish pharma with emerging ophthalmology focus and international growth momentum, but selective entry warranted given recent market pressures. Faes Farma demonstrates solid fundamentals as an established 90+ year pharmaceutical company with international presence, diversified portfolio, and recent strategic focus on high-growth areas like ophthalmology. However, the company faces.

What is Faes Farma, S.A.'s industry? Faes Farma, S.A. (faesfarma.com) operates in Pharmaceutical Manufacturing & Distribution. AskCyborg classifies Faes Farma, S.A. under Pharmaceutical Manufacturing & Distribution in its company registry.

Faes Farma is a Spanish pharmaceutical company founded in 1933 with an extensive international track record, which researches, produces and markets pharmaceutical products and raw materials, exporting to numerous coun...

6/ 10Solid

Cyborg Score thesis

Established Spanish pharma with emerging ophthalmology focus and international growth momentum, but selective entry warranted...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing & Distribution
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Faes Farma, S.A. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Faes Farma, S.A.

AskCyborg analysts argue the bull and bear cases for Faes Farma, S.A. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Faes Farma, S.A. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Faes Farma, S.A. Overview

Pro stress-test →

Faes Farma is a Spanish pharmaceutical company founded in 1933 with an extensive international track record, which researches, produces and markets pharmaceutical products and raw materials, exporting to numerous countries. The company also has a division dedicated to animal nutrition and health (FARM Faes), which includes companies such as Ingaso Farm, Capselos, Cidosa and Tecnovit.

Strategic Profile

Pro stress-test →

Ophthalmology represents a key strategic opportunity for Faes Farma as it is a therapeutic area with expected double-digit growth. The pharmaceutical business grew by +9% to €269 million, with international markets (+14%) and licenses (+13%) continuing to be the main drivers of growth. The company's research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome.

Competitive Landscape

Pro stress-test →

The company does most of its business in Spain and Portugal, but sales in more than 100 other countries are growing, with Latin America and Africa leading that growth. As a mid-sized Spanish pharmaceutical company, Faes Farma competes with both larger global pharma players and regional specialists across multiple therapeutic areas.

Industry Context

Faes Farma, S.A. operates in Pharmaceutical Manufacturing & Distribution.

Key facts

Founded: 1933 · Headquarters: Leioa, Spain · Employees: 1766 · Revenue: €269M (Pharma division 2025)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Faes Farma, S.A..

  • Ophthalmology is a key growth opportunity with expected double-digit growth
  • Pharmaceutical division achieved 9% growth to €269M, with international markets driving 14% growth
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026Q4 2025 earnings release published
  • Nov 2025Ophthalmology acquisitions consolidated as transformational strategy milestone
  • +1 moreTrack every material event for Faes Farma, S.A. as it happens. Explore monitoring →
Get alerted when Faes Farma, S.A. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

GrifolsSpanish pharmaceutical and diagnostics company→Roche PharmaGlobal pharmaceutical leader→NovartisGlobal diversified pharma company→

Compare Faes Farma, S.A. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Faes Farma, S.A. operates in Pharmaceutical Manufacturing & Distribution. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing & Distribution research →
NEW · MCP server

Ask your AI assistant about Faes Farma, S.A.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Faes Farma, S.A. and its top competitor on Cyborg Score”
“What did Faes Farma, S.A. do this quarter?”
“Is Faes Farma, S.A. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Faes Farma, S.A. do?+
Faes Farma is a Spanish pharmaceutical company founded in 1933 with an extensive international track record, which researches, produces and markets pharmaceutical products and raw materials, exporting to numerous coun...
What is Faes Farma, S.A.'s Cyborg Score?+
Faes Farma, S.A. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Faes Farma, S.A.'s main competitors?+
Named competitors include Grifols, Roche Pharma, Novartis. The full competitive landscape is in the AskCyborg report.
How can I get the full Faes Farma, S.A. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Faes Farma, S.A. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Faes Farma, S.A. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceutical Manufacturing & Distribution research

Companies in the same sector and named competitors, ranked by Cyborg Score.

5Grifols, S.A.7Novartis AG